SF163 • 2026

A bill for an act relating to the definition of medical cannabidiol.

Healthcare

Passed Legislature

This bill passed both chambers and reached final enrollment, even if later executive action is not shown here.

Sponsor: WEBSTER
Last action: 2025-02-20
Official status: Subcommittee recommends amendment and passage.
Effective date: Not listed

Plain English Breakdown

Using official source text because the generated explanation was unavailable or could not be confirmed against the official bill text.

A bill for an act relating to the definition of medical cannabidiol.

What This Bill Does

A bill for an act relating to the definition of medical cannabidiol.

Limits and Unknowns

This entry is temporarily using official source text because the generated explanation could not be confirmed against the official bill text during the last sync.

Bill History

2025-02-20 Iowa Legislature
Subcommittee recommends amendment and passage.
2025-02-19 Iowa Legislature
Subcommittee Meeting: 02/20/2025 2:00PM Senate Lounge.
2025-02-04 Iowa Legislature
Subcommittee: Klimesh, Campbell, and Trone Garriott. S.J. 194 .
2025-01-29 Iowa Legislature
Introduced, referred to Health and Human Services. S.J. 161 .

Official Summary Text

A bill for an act relating to the definition of medical cannabidiol.

Current Bill Text

Read the full stored bill text

Senate

File

163

-

Introduced

SENATE

FILE

163

BY

WEBSTER

A

BILL

FOR

An

Act

relating

to

the

definition

of

medical

cannabidiol.

1

BE

IT

ENACTED

BY

THE

GENERAL

ASSEMBLY

OF

THE

STATE

OF

IOWA:

2

TLSB

2002XS

(1)

91

ss/ko

S.F.

163

Section

1.

Section

124E.2,

subsection

10,

Code

2025,

is

1

amended

by

striking

the

subsection

and

inserting

in

lieu

2

thereof

the

following:

3

10.

“Medical

cannabidiol”

means

any

species

of

the

genus

4

cannabis

plant,

or

any

mixture

or

preparation

thereof,

5

including

whole

plant

extracts

and

resins,

that

is

delivered

6

in

any

of

the

following

forms:

7

a.

Oral

forms,

including

but

not

limited

to:

8

(1)

Tablets.

9

(2)

Capsules.

10

(3)

Liquids.

11

(4)

Tinctures.

12

(5)

Sublingual

forms.

13

b.

Topical

forms,

including

but

not

limited

to:

14

(1)

Gels.

15

(2)

Ointments,

creams,

or

lotions.

16

(3)

Transdermal

patches.

17

c.

Inhaled

forms,

limited

to:

18

(1)

Nebulizable

inhaled

forms.

19

(2)

Vaporizable

dried

raw

cannabis.

20

(3)

Other

vaporizable

forms

of

cannabis.

21

EXPLANATION

22

The

inclusion

of

this

explanation

does

not

constitute

agreement

with

23

the

explanation’s

substance

by

the

members

of

the

general

assembly.

24

This

bill

relates

to

the

medical

cannabidiol

program.

The

25

bill

changes

the

definition

of

“medical

cannabidiol”

to

include

26

specific

forms

of

oral,

topical,

and

inhalable

cannabis.

27

-1-

LSB

2002XS

(1)

91

ss/ko

1/

1